Project Grant HT9425261E287
- Federal Grant Award Summary The Children's Hospital of Philadelphia (CHOP), through its Research Institute Division, received a $326,712 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The award funds a research initiative titled "Structured Lipid Nutrition Intervention on Symptom Management and Quality of Life," to be conducted at CHOP's...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,501 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on developing peptide-centric chimeric antigen receptor (CAR) T-cell therapies for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $712,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, with completion targeted for August 31, 2027. The award funds the development of a GPC2 CAR T cell-amplifying extracellular vesicle vaccine, representing a translational immunotherapy research initiative aimed at advancing cancer...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $676,117 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, with completion scheduled for August 31, 2029. The research project focuses on expanded GAA-GGA chimeric repeats in Friedreich Ataxia, a rare neurological genetic disorder. This award supports biomedical research aimed at advancing medical...
- The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic...
- The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
- Federal Grant Award Summary Children's Research Institute received a $777,659 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award supports research titled "Use of ProResolution and Restorative Pharmacology Approaches for DMD Therapy," focusing on the development of innovative therapeutic interventions for Duchenne muscular dystrophy (DMD). The...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Boston Children's Hospital a $559,998 Project Grant effective July 1, 2026, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award funds basic and applied biomedical research titled "Defining the Cell of Origin and Mechanisms of Initiation for Pediatric Melanoma," conducted at the institution's Boston, Massachusetts facility. This project contributes to the...
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $356,000.00 to The Children's Hospital of Philadelphia (CHOP) to study the impact on ketosis phenotype. The performance period for this award is from Sep 1, 2024 to Aug 31, 2026. As a leading pediatric research institution, CHOP leverages its expertise in areas such as genetic disorders and neurological conditions to contribute to...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...
The Children's Hospital of Philadelphia (CHOP) Research Institute received a $1.12 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the "Building of the Child and Adolescent Thyroid Consortium," with performance through August 31, 2029. This award supports the establishment and operational infrastructure of a research consortium focused on pediatric thyroid health and disease, aligned with the DHA's mission to advance biomedical research addressing Service Member and military population health needs. CHOP, a leading pediatric biomedical research institution based in Philadelphia, will leverage its Research Institute Division and clinical research infrastructure to develop consortium governance structures, coordinate multi-institutional participation, and establish standardized protocols and data-sharing mechanisms to support collaborative thyroid-focused research across participating pediatric institutions. As a primary federal grant recipient with substantial NIH funding experience and an active portfolio within the DHA's Military Medical Research and Development program, CHOP will deliver research coordination, clinical trial infrastructure development, and translational science capacity to support the consortium's long-term collaborative research objectives through the three-year award period ending August 31, 2029.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 6/24/26 |